Last updated on September 2014

Study of Radium-223 Dichloride Versus Placebo and Hormonal Treatment as Background Therapy in Subjects With Bone Predominant HER2 (Human Epidermal Growth Factor Receptor 2) Negative Hormone Receptor Positive Metastatic Breast Cancer


Brief description of study

The objective of this study is to assess efficacy and safety of radium-223 dichloride in subjects with human epidermal growth factor receptor 2 negative (HER2 negative) hormone receptor positive breast cancer with bone metastases treated with hormonal treatment background therapy.

Clinical Study Identifier: NCT02258464

Contact Investigators or Research Sites near you

Start Over

Bayer Clinical Trials Contact

Bakersfield, CA United States
  Connect »

Bayer Clinical Trials Contact

Long Beach, CA United States
  Connect »

Bayer Clinical Trials Contact

New Haven, CT United States
  Connect »

Bayer Clinical Trials Contact

Fort Lauderdale, FL United States
  Connect »

Bayer Clinical Trials Contact

Plantation, FL United States
  Connect »

Bayer Clinical Trials Contact

Cedar Rapids, IA United States
  Connect »

Bayer Clinical Trials Contact

Annapolis, MD United States
  Connect »

Bayer Clinical Trials Contact

Ann Arbor, MI United States
  Connect »

Bayer Clinical Trials Contact

Rochester, MN United States
  Connect »

Bayer Clinical Trials Contact

Saint Louis, MO United States
  Connect »

Bayer Clinical Trials Contact

Lake Success, NY United States
  Connect »

Bayer Clinical Trials Contact

Cleveland, OH United States
  Connect »

Bayer Clinical Trials Contact

Philadelphia, PA United States
  Connect »

Bayer Clinical Trials Contact

Pittsburgh, PA United States
  Connect »

Bayer Clinical Trials Contact

Watertown, SD United States
  Connect »

Bayer Clinical Trials Contact

Clermont Ferrand Cedex 1, France
  Connect »

Bayer Clinical Trials Contact

La Roche Sur Yon Cedex, France
  Connect »

Bayer Clinical Trials Contact

Vandoeuvre Les Nancy, France
  Connect »

Bayer Clinical Trials Contact

Suwon-si, Korea, Republic of
  Connect »

Bayer Clinical Trials Contact

Incheon, Korea, Republic of
  Connect »

Bayer Clinical Trials Contact

L'Hospitalet de Llobregat, Spain
  Connect »